IP Library Granted Patent US 7,566,790
Granted Patent B2
US 7,566,790 · App. 11/150,596 · Granted Jul 28, 2009

Intermediates and the synthesis of modified carbocyanine dyes and their conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,566,790
App. No.
11/150,596
Granted
Jul 28, 2009
Kind
B2
Abstract

Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that are uniformly superior to those of conjugates of spectrally similar dyes wherein attachment is at a different position. The invention includes derivative compounds having one or more benzo nitrogens.

Claims (45)

1. A compound having the formula:

and its salts, wherein

R 3 is -L-R x ; or -L-S C ;

R 4 is -L-R x ; or -L-S C , a C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 alkylamino, or C 2 -C 12 dialkylamino, or C 3 -C 18 trialkylammonium; or

R 3 and R 4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x ; or -L-S C ;

L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;

R x is a reactive group that is an acrylamide, an activated ester of a carboxylic acid, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, an amine, an anhydride, an aniline, an aryl halide, an azide, an aziridine, a boronate, a carboxylic acid, a diazoalkane, a haloacetamide, a halotriazine, a hydrazide, an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a reactive platinum complex, a sulfonyl halide, a thiol group, or a photoactivatable group;

S c is a conjugated substance that is an antibody, an amino acid, an avidin or streptavidin, a biotin, a blood component protein, a blood vessel proliferation inhibition factor, a dextran, an enzyme, an enzyme inhibitor, a hormone, an lgG-binding protein, an on-complexing moiety, a fluorescent protein, a growth factor, a lectin, a lipopolysaccharide, a metal-binding protein, a microorganism or portion thereof, a neuropeptide, a non-biological microparticle, a nucleotide, an oligonucleotide, a peptide toxin, a phospholipid-binding protein, a small-molecule drug, a structural protein, or a tyramide;

Y represents the atoms necessary to form an aromatic ring having 6 atoms in the ring, which atoms are selected from —CH, —C, and —CR 1 , and each R 1 is independently -L-R x , -L-S c , amino, sulfo, trifluoromethyl, halogen; C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylamino, or C 2 -C 12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;

R 2 is -L-R x , -L-S c , a C 1 -C 22 alkyl or C 7 -C 22 arylalkyl, each alkyl portion of which optionally incorporates up to six hetero atoms, selected from N, O and S, and each alkyl portion of which is optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 alkylamino, C 2 -C 12 dialkylamino, or C 3 -C 18 trialkylammonium; and

α is 0 or 1.

2. The compound according to claim 1 , wherein the atoms of Y are —CH or —CR 1 and R 1 is C 1 -C 6 alkyl optionally substituted by sulfo.

3. The compound according to claim 1 , wherein R 1 is sulfo or sulfoalkyl.

4. The compound according to claim 1 , wherein

R 2 is alkyl or sulfoalkyl;

R 3 is carboxyalkyl; and

R 4 is alkyl.

5. A compound having the formula:

and its salts, wherein

R 3 is -L-R x ;

R 4 is a C 1 -C 22 alkyl; or

R 3 and R 4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x ;

L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;

R x is a reactive group that is an amine or a carboxylic acid;

Y represents the atoms necessary to form an aromatic ring having 6 atoms in the ring, which atoms are selected from —CH, —C, and —CR 1 , and each R 1 is independently amino, sulfo, trifluoromethyl, halogen; C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylamino, or C 2 -C 12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy;

R 2 is an alkyl or sulfoalkyl; and

α is 0 or 1.

6. A compound having the formula:

and its salts, wherein

R 3 is -L-R x ; or -L-S c ;

R 4 is a C 1 -C 22 alkyl, optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxy, sulfo, phosphate, amino, sulfate, phosphonate, cyano, nitro, azido, C 1 -C 6 alkoxy, C 1 -C 6 alkylamino, or C 2 -C 12 dialkylamino, or C 3 -C 18 trialkylammonium; or,

R 3 and R 4 taken in combination complete a five- or six-membered saturated or unsaturated ring that is substituted by -L-R x or -L-S c ; and

L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds;

R x is a reactive group that is an acrylamide, an activated ester of a carboxylic acid, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, an amine, an anhydride, an aniline, an aryl halide, an azide, an aziridine, a boronate, a carboxylic acid, a diazoalkane, a haloacetamide, a halotriazine, a hydrazide, an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a reactive platinum complex, a sulfonyl halide, a thiol group, or a photoactivatable group;

S c is a conjugated substance that is an antibody, an amino acid, an avidin or streptavidin, a biotin, a blood component protein, a blood vessel proliferation inhibition factor, a dextran, an enzyme, an enzyme inhibitor, a hormone, an IgG-binding protein, an ion-complexing moiety, a fluorescent protein, a growth factor, a lectin, a lipopolysaccharide, a metal-binding protein, a microorganism or portion thereof, a neuropeptide, a non -biological microparticle, a nucleotide, an oligonucleotide, a peptide toxin, a phospholipid-binding protein, a small-molecule drug, a structural protein, or a tyramide;

R 6 through R 9 are independently H, -L-R x , -L-S c , amino, sulfo, trifluoromethyl, halogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylamino, or C 2 -C 12 dialkylamino, each of which is optionally further substituted by carboxy, sulfo, amino, or hydroxy; and

R 2 is a C 1 -C 6 alkyl or C 1 -C 6 alkyl substituted by sulfo.

7. The compound according to claim 6 , having the structure:

and its salts, wherein

R 2 is an alkyl or sulfoalkyl;

R 7 is an alkyl or sulfo;

R 4 is a C 1 -C 22 alkyl; and

R 3 is -L-R x ;

wherein L is a single covalent bond, or a covalent linkage that is linear or branched, cyclic or heterocyclic, saturated or unsaturated, having 1-16 nonhydrogen atoms selected from the group consisting of C, N, P, O, and S, such that the linkage contains any combination of ether, thioether, amine, ester, amide bonds; or single, double, triple or aromatic carbon-carbon bonds; or phosphorus-oxygen, phosphorus-sulfur, nitrogen-nitrogen, nitrogen-oxygen, or nitrogen-platinum bonds; or aromatic or heteroaromatic bonds; and

R x is a reactive group that is an amine or a carboxylic acid.

Assignments (3)
LIEN RELEASE Recorded Apr 8, 2013
From: BANK OF AMERICA, N.A.
To: MOLECULAR PROBES, INC.
Reel/Frame 030173/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2010
From: MOLECULAR PROBES, INC.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 024686/0321 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: MOLECULAR PROBES, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 021930/0243 →